Next Article in Journal
Bile Acid Regulates the Colonization and Dissemination of Candida albicans from the Gastrointestinal Tract by Controlling Host Defense System and Microbiota
Next Article in Special Issue
Investigations upon the Improvement of Dermatophyte Identification Using an Online Mass Spectrometry Application
Previous Article in Journal
Bioprocesses with Reduced Ecological Footprint by Marine Debaryomyces hansenii Strain for Potential Applications in Circular Economy
Previous Article in Special Issue
Real-Time PCR Assay for the Detection of Dermatophytes: Comparison between an In-House Method and a Commercial Kit for the Diagnosis of Dermatophytoses in Patients from Dakar, Senegal
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JoF
Volume 7
Issue 12
10.3390/jof7121029
jof-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Towards a Standardized Procedure for the Production of Infective Spores to Study the Pathogenesis of Dermatophytosis

by
Emilie Faway
1,†,
Cindy Staerck
2,†,
Célya Danzelle
2,
Sophie Vroomen
2,
Christel Courtain
1,
Bernard Mignon
2,*,‡ and
Yves Poumay
1,*,‡
1
Molecular Physiology Research Unit, NAmur Research Institute for Life Sciences (URPHYM-NARILIS), Faculty of Medicine, University of Namur, 5000 Namur, Belgium
2
Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
These authors contributed equally to this work.
J. Fungi 2021, 7(12), 1029; https://doi.org/10.3390/jof7121029
Submission received: 28 October 2021 / Revised: 23 November 2021 / Accepted: 26 November 2021 / Published: 30 November 2021
(This article belongs to the Special Issue Epidemiology and Pathogenesis of Dermatophytes)
Browse Figures
Versions Notes

Abstract

:
Dermatophytoses are superficial infections of human and animal keratinized tissues caused by filamentous fungi named dermatophytes. Because of a high and increasing incidence, as well as the emergence of antifungal resistance, a better understanding of mechanisms involved in adhesion and invasion by dermatophytes is required for the further development of new therapeutic strategies. In the last years, several in vitro and in vivo models have emerged to study dermatophytosis pathogenesis. However, the procedures used for the growth of fungi are quite different, leading to a highly variable composition of inoculum for these models (microconidia, arthroconidia, hyphae), thus rendering difficult the global interpretation of observations. We hereby optimized growth conditions, including medium, temperature, atmosphere, and duration of culture, to improve the sporulation and viability and to favour the production of arthroconidia of several dermatophyte species, including Trichophyton rubrum and Trichophyton benhamiae. The resulting suspensions were then used as inoculum to infect reconstructed human epidermis in order to validate their ability to adhere to and to invade host tissues. By this way, this paper provides recommendations for dermatophytes culture and paves the way towards a standardized procedure for the production of infective spores usable in in vitro and in vivo experimental models.

1. Introduction

Dermatophytoses are superficial infections of the skin, hair, and nails due to filamentous and keratinolytic fungi named dermatophytes [1]. Currently, dermatophytoses constitute the most common mycosis worldwide, affecting 20–25% of the global population [2], and up to 50% among populations at risk, such as sportsmen and diabetic patients [3,4,5]. Genetic predispositions also exist and heredity participates, along with lifestyle, in the increase of dermatophytosis prevalence observed in the last decades [6,7]. Classical antifungals, such as azole derivatives and terbinafine, are generally efficient to treat dermatophytosis [8], but their use is associated with potential toxicity when systemic administration is required [9] and must cope with the growing emergence of resistant strains [10,11,12,13,14].
Because of this high and still increasing prevalence of dermatophytosis, as well as the difficulties encountered with currently available treatments, more research is needed to elucidate mechanisms responsible for fungal adherence and invasion of the host tissue. For this purpose, several in vitro and in vivo models of infection by dermatophytes have been developed (for reviews, see [15,16] respectively).
Experimental infection models described in the literature use different compositions of inoculum, consisting in suspensions enriched in unicellular infective spores, namely microconidia [17,18,19,20,21,22,23] or arthroconidia [24,25,26,27,28,29], or in a mix of microconidia and hyphae [30,31,32,33,34,35]. Microconidia, as well as macroconidia, are a type of thallic spores resulting from lateral or terminal budding of hyphae. Although micro- and macroconidia are easier to produce in culture, and thus frequently used as infective spores in most experimental models, they have never been observed in natural lesions [36]. In contrast, arthroconidia, produced by fragmentation and disarticulation of hyphae septate [37,38], are recognized as natural vectors of dermatophytosis [36]. However, even though their use appears more representative of natural infection, arthroconidia are less frequently used in experimental models since their formation is particularly difficult to induce in vitro. Arthroconidia production was nevertheless documented in some studies using T. mentagrophytes [37,39,40,41,42] or M. canis [25], and more recently with T. rubrum [43,44].
This heterogeneity in the composition of inoculum, produced in various conditions of culture, including media, temperature, atmosphere, or duration, could influence the development of infection, rendering impossible any comparison between the observations obtained from different experimental models. Thus, overall conclusions about the pathogenic mechanisms responsible for dermatophytosis remain hard to define. In this paper, we assessed the growth and production of spores, especially arthroconidia, by several dermatophyte species frequently isolated from human lesions, in different culture conditions, with the aim to define a standardized procedure for the production of infective spores usable as inoculum in experimental in vitro and in vivo models. In addition, the infectious potential of these inocula was checked through an evaluation of infection development in a model of reconstructed human epidermis (RHE).

2. Materials and Methods

2.1. Dermatophyte Strains

This study was conducted on a panel of 13 dermatophyte strains described in Table 1 and obtained from IHEM (Institute of Hygiene and Epidemiology-Mycology section) from the Scientific Institute of Public Health (Brussels, Belgium). The strains were firstly grown on a homemade Sabouraud (SAB) medium (Table 2) plate at 30 °C for 14 days.

2.2. Growth Evaluation

The growth capacity of dermatophytes was determined using five different agar media: Sabouraud (SAB), potato dextrose agar (PDA), yeast peptone dextrose (YPD), malt medium (MALT), and yeast extract nitrogen (YEN). The composition of each medium, as well as the suppliers for all ingredients used, are described in Table 2. Practically, fungi were grown on SAB at 30 °C for 14 days, after which the fungal material was scraped with a scalpel blade and transferred in PBS (pH 7.2). Fungal suspensions were centrifuged at 3000× g for 5 min, before pellets were washed three times with PBS and finally resuspended in an adequate volume of PBS to obtain a concentration of 1 × 105 colony-forming unit (CFU) per mL. Five microliters of the resulting fungal suspension were then spotted on the centre of each medium plate and incubated in the dark at 30 °C. The diameter of fungal colonies was measured every day for 31 days and radial growths were determined during the exponential phase by analysis of the growth curves.

2.3. Sporulation Evaluation

The sporulation of dermatophytes was assessed after 31 days of growth at 30 °C on the five used agar media (SAB, PDA, YPD, MALT and YEN, Table 2). Practically, the fungal material was scrapped from the surface of the agar plate with a scalpel blade and suspended in PBS (pH 7.2). Recovered suspensions were then filtered through three Miracloth layers (22–25 µm pore size; cat. no. 475855; Merck KGaA, Darmstadt, Germany) to remove hyphae and centrifuged at 3000× g for 5 min. Pellets were washed three times with PBS and resuspended in 5 mL PBS. Total spore concentration, including microconidia, macroconidia, and arthroconidia, was microscopically enumerated using a Thoma cell counting chamber.

2.4. Production of Infective Spore Suspensions

The production of a suspension of infective spores adequate for use in experimental models was evaluated on three different homemade media (SAB, PDA and YEN, Table 2). Briefly, after growth on SAB for 14 days, the fungal material was scraped with a scalpel blade, transferred in PBS (pH 7.2), and seeded on SAB, PDA, or YEN media for sporulation. The plates were incubated at 30 °C under 12% CO2 or at 37 °C under 10% CO2, for 10, 21, or 31 days. Spore suspensions were then recovered as previously described in Section 2.3, with an additional step of stirring in order to efficiently dissociate arthroconidia and microconidia from hyphae.
The viable fungal concentration of the resulting suspensions was determined by CFU counting of serial dilutions after three days of incubation at 30 °C on SAB, and the total spore concentration was determined under light microscopy as described in Section 2.3. Simultaneously, the proportion of arthroconidia was calculated relative to the total spore concentration after examining five randomly selected microscopical fields under ×400 magnification. The spore suspensions were finally observed and pictured under differential interference contrast (DIC) microscopy (Olympus; Tokyo, Japan).

2.5. Infection Development on Reconstructed Human Epidermis

Initially, the inoculum used in our model of infection on RHE consisted in a suspension of spores recovered after a 21-days incubation on YEN at 30 °C under 12% CO2 [28]. Based on our previous results, herein, we compared inoculum prepared using this conventional procedure with a spore suspension recovered after a 10-days incubation on PDA at 30 °C under 12% CO2, appearing as the optimal method to obtain a high viable fungal concentration. The preparation of these spore suspensions was performed as described in Section 2.4. Spores were stored at 4 °C and used within one month.
The assays of infection on RHE were performed for T. benhamiae IHEM 20163 and T. rubrum IHEM 13894 strains. The inoculum was adjusted at the required quantity by dilution in PBS: 30 CFU for T. benhamiae and 1000 CFU for T. rubrum, respectively corresponding to densities of about 53 per cm2 and 1700 per cm2.

2.5.1. Production of RHE and Infection by Dermatophytes

RHE were prepared as previously described [46]. Briefly, normal human keratinocytes were isolated from skin samples obtained from plastic surgery (Dr. Bienfait and Dr. Blairvacq, Clinique St-Luc, Namur-Bouge, Belgium). After prior amplification in EpiLife medium (cat. no. M-EPI-500-CA; Life Technologies, Waltham, MA, USA) supplemented with Human Keratinocyte Growth Supplement (HKGS; cat. no. S-001-5; Life Technologies, Waltham, MA, USA), primary keratinocytes were seeded at a high density of 250,000 cells per cm2 onto polycarbonate culture insert characterized by pores of 0.4 µm diameter (cat. no. PIHP01250; Merck KGaA, Darmstadt, Germany) in EpiLife medium supplemented with HKGS and 1.5 mM Ca2+. After 24 h, keratinocytes were exposed to the air-liquid interface by removing the culture medium above the insert, while the medium under the insert was replaced by EpiLife medium supplemented with HKGS, 1.5 mM Ca2+, 10 ng/µL keratinocytes growth factor (KGF; cat. no. 251-KG; R&D Systems, Abingdon, UK) and 50 µg/mL vitamin C (2-phospho-L-ascorbic acid trisodium salt; cat. no. 49752; Merck KGaA, Darmstadt, Germany). Keratinocytes were maintained at 37 °C in a humidified atmosphere containing 5% CO2 with medium under the insert renewed every two days. After 11 days, fully differentiated epidermis can be obtained and used for infection by dermatophytes.
Infection of RHE by dermatophytes was performed as described in Faway et al. [28]. Practically, an inoculum made of infective spore suspensions, produced as depicted in Section 2.4, was topically applied onto the surface of RHE on the day of infection. At this step, an additional inoculum was seeded onto SAB plates to monitor the fungal load by counting CFU after three days of incubation at 30 °C (internal control). Four hours after infection, the surface of RHE was rinsed three times with PBS in order to eliminate non-adherent spores and to expose again the cultured keratinocytes to the air–liquid interface. Non-adherent spores recovered during washes were counted onto SAB, in order to evaluate the fraction of remaining adherent spores. Finally, infected RHE were maintained in culture for four additional days with culture medium and the tissue was renewed every day.

2.5.2. Histological Analysis

Infected RHE were recovered each day during the four days following infection, fixed in 4% formaldehyde solution, and histologically processed before periodic-acid Schiff (PAS) staining with pre-treatment using α-amylase and hemalun counterstaining, as described by Faway et al. [28].

2.5.3. Measurement of Infection Level

The quantification of the infection level on RHE was performed by the assessment of the copy number of the dermatophyte 18S rDNA gene using qPCR as previously described [28]. Briefly, total DNA was extracted from infected RHE using the DNeasy® Blood & Tissue Kit (cat. no. 69504; Qiagen, Hilden, Germany) after tissue homogenization using Tissue Grinder (cat. no. NG010; NIPPON Genetics EUROPE, Duren, Germany). Quantitative PCR was then performed using Light Cycler 96 (Roche, Basel, Switzerland) and the PCR mixture was made of TakyonTM No ROX SYBR® Master Mix (cat. no. UF-NSMT-B0701; Eurogentec, Seraing, Belgium), 300 nM of each primer, and 20 ng of DNA. Primer sequences were chosen to amplify the 18S rDNA gene from several dermatophyte species, including T. rubrum and T. benhamiae (18SrDNA-F 5′-TAACGAACGAGACCTTAACC-3′ and 18SrDNA-R 5′-TTATTGCCTCAAACTTCCAT-3′, described in Paugam et al. [47]). Absolute quantification was realized thanks to a standard curve made of known 18S rDNA copy number samples. These samples were obtained after DNA extraction from T. rubrum or T. benhamiae mycelium grown on SAB plates, PCR amplification of the 18S rDNA gene using the PlatinumTM SuperFiTM DNA Polymerase (cat. no. MAN0014882; Invitrogen, Carlsbad, CA, USA), and purification by the MinElute® PCR Purification Kit (cat. no. 28004; Qiagen, Hilden, Germany). For more details, please refer to Faway et al. [28].

2.5.4. Epidermal Barrier Integrity Monitoring

The integrity of the RHE epidermal barrier was monitored during infection by measurement of the trans-epithelial electrical resistance (TEER) using a Millicell ERS-2 Voltohmmeter (cat. no. MERS00002; Merck KGaA, Darmstadt, Germany). These measurements are expressed as a percent of TEER values measured through RHE before infection.

2.5.5. RNA Extraction, Reverse Transcription and Quantitative PCR

Expression of proinflammatory cytokines and antimicrobial peptides by keratinocytes during infection of RHE was assessed by RT-qPCR after total RNA extraction. RPLP0 was used as a reference gene [48] and results are expressed as relative expression compared to control non-infected RHE. Practically, total RNA was extracted from infected and control RHE using RNeasy Mini Kit (cat. no. 74104; Qiagen, Hilden, Germany) according to the manufacturer’s instructions, and 1 µg of RNA was reverse-transcribed into cDNA using the SuperScript III Reverse Transcriptase kit (cat. no. 18080; Invitrogen, Carlsbad, CA, USA). The qPCR mixture contained TakyonTM No ROX SYBR® Master Mix (cat. no. UF-NSMT-B0701; Eurogentec, Seraing, Belgium), 300 nM of each primer and 5 µL of cDNA diluted 1:20 in distilled water. The qPCR was performed using Light Cycler 96 (Roche, Basel, Switzerland). All primers used for qPCR were designed in-house using Primer-BLAST online software (https://www.ncbi.nlm.nih.gov/tools/primer-blast/ accessed on 1 September 2021) and showed efficacy between 90% and 110% [29]. Primers sequences are listed in Table 3.

2.5.6. ELISA Assays

The release of the proinflammatory cytokines IL-1α and IL-8 by keratinocytes during infection of RHE was monitored by ELISA assay performed on culture medium. Commercial ELISA kits, Human IL-1 alpha/IL1F1 DuoSet ELISA and Human IL-8/CXCL8 DuoSet ELISA (cat. no. DY200 and DY208; R&D Systems, Abingdon, UK), were used according to the manufacturer’s instructions.

2.6. Statistical Analysis

Results for each assay are expressed as the means with standard deviations, or individual values, of at least triplicate experiments performed independently and using freshly prepared fungal suspensions. Data were plotted using GraphPad Prism 9 software. Results were analysed by one-way (ANOVA1) or two-way (ANOVA2) variance analysis using GraphPad Prism 9 and SigmaPlot version 11.0 software, and were considered as significantly different with a p-value < 0.05.

3. Results

3.1. Growth and Sporulation of Dermatophytes Are Improved on PDA

The growth of dermatophytes was monitored on different media (SAB, PDA, YPD, MALT, and YEN) by determination of colony diameter and radial growth. Strangely, YEN medium, classically used for the production of spore suspensions of M. canis appeared not suitable for Trichophyton species (Figure S1B). Globally, the colony diameters of all the strains used in this study were higher on PDA than on the other media (Figure S1A) and these data were in accordance with the radial growth determined on PDA (Figure S2). Notably, T. rubrum IHEM 13894 presented a diameter about twofold superior on SAB and PDA as compared to other media, without significant improvement of the radial growth (Figure 1A,B and Figure S3). For T. benhamiae IHEM 20163, the colony size after 10 days was even more enhanced on PDA than on SAB (Figure 2A,B and Figure S3). In addition, all the strains, except M. audouinii IHEM 10316, T. rubrum IHEM 13894, and T. tonsurans IHEM 24958, exhibited a reproductive fungal growth curve on PDA, with few variations between replicate assays.
In parallel to growth, the sporulation of dermatophytes was assessed on each tested medium by determining the total spore concentration after 31 days of incubation, when the strains were in stationary phase on most media. Spores were mainly represented by microconidia and to a lesser extent by arthroconidia, with macroconidia being extremely rare due to the porosity of the Miracloth filter used for spore production (see Section 2.3 in Section 2). On PDA, the amount of spores produced by T. rubrum IHEM 13894 was significantly higher than on YPD, MALT, and YEN (Figure 1C). The same trend, whereas not statistically significant, was observed for T. benhamiae IHEM 20163 (Figure 2C). Consistently, PDA significantly increased the total spore concentration for M. canis IHEM 22957 compared to SAB, YPD, and YEN, and for T. mentagrophytes IHEM 25841 and TIMM 2789 compared to YEN (Figure S4). For all other strains, sporulation was higher on PDA than on the other media, but without significant difference.

3.2. High Viable Fungal Concentration Is Obtained after Incubation on PDA

In order to produce fungal suspensions suitable for use in experimental models, i.e., containing mainly unicellular spores (microconidia and ideally arthroconidia) with sufficient concentration and viability (>106 CFU/mL), dermatophytes were incubated for 10 or 21 days on SAB, YEN, and PDA at 30 °C under 12% CO2 or at 37 °C under 10% CO2. After the recovery of spore suspensions, the viable fungal concentration was evaluated by CFU counting.
For all the strains, except T. tonsurans IHEM 24958 and M. audouinii IHEM 10316, growth on PDA at 30 °C under 12% CO2 resulted in sufficient quantity of viable fungal elements (Figure 1D, Figure 2D and Figures S4–S6). Furthermore, for Trichophyton species, an incubation period of 10 days rather than 21 days did not have a significant negative impact on viable fungal concentration. For some strains, the variability of the fungal concentration obtained between replicates was even reduced, ultimately allowing a reduction in the culture time required. In contrast, for Microsporum species, a culture duration of less than 21 days appeared inappropriate due to lower viable fungal concentration.
For M. audouinii IHEM 10316 and T. tonsurans IHEM 24958, viable fungal concentration was extremely low, i.e., less than 104 CFU/mL, irrespective of conditions and media (Figures S5 and S7). Extending the incubation time to 31 days somehow increased the viable concentration, but it remained low and insufficient for further use in experiments.

3.3. Production of Arthroconidia Is Highly Variable According to Strains and Culture Conditions

Arthroconidia were observed using DIC microscopy and counted using a Thoma chamber under light microscopy to determine their percentage in the spore suspensions (see Section 2.4). In Microsporum species, the arthroconidia were rather rectangular in shape, with straight or curved edges, respectively for M. audouinii and M. canis (Figure S8). In contrast, their morphology was highly variable among Trichophyton species, with rectangular, spherical, or ovoid shapes (Figure 1E, Figure 2E and Figure S8). Furthermore, the morphology of arthroconidia may differ between their formation inside the hyphae and their release as individual cells, as for example arthroconidia of T. interdigitale appearing rectangular-shaped inside hyphae and spherical-shaped once they became individuals, while the contrary was observed for the arthroconidia of T. mentagrophytes (Figure S8).
The percentage of arthroconidia in spore suspensions varied considerably between culture conditions and between replicates for a given condition (Figure 1F, Figure 2F, and Figure S9). Furthermore, for each of the dermatophyte strains, the conditions favouring arthroconidial production, and those allowing sufficient viability (>106 CFU/mL) to be achieved, were not the same. Indeed, using a culture on PDA at 30 °C under 12% CO2 for 10 (Trichophyton spp.) or 21 days (Microsporum spp.), a condition defined as optimal in terms of viability, the proportion of arthroconidia was extremely variable and quite low (<20%) for the majority of strains (Table 4, Figure S10).

3.4. Spore Suspensions Recovered after 10 Days on PDA at 30 °C under 12% CO2 Are Adequate to Induce Infection on RHE

Mainly based on the viable fungal concentration, a 10-day (21-days for Microsporum species) incubation on PDA at 30 °C under 12% CO2 appeared to be the optimal condition for the production of spore suspensions suitable as inoculum in experimental models. Indeed, in such conditions, the viable fungal concentration was above 106 CFU/mL, a concentration sufficient to induce infection when used in in vitro [15] and in vivo models [16]. Nevertheless, no information is available in the literature on the pathogenicity of spore suspensions of dermatophytes produced in such conditions. Thus, the infectious ability of these suspensions was evaluated in RHE model. Since the dermatophytosis model on RHE was initially developed using spore suspensions recovered after 21 days of incubation on YEN at 30 °C under 12% CO2 as an inoculum [28], herein, we compared the infection development on RHE after topical application of spore suspensions recovered following the “conventional procedure” (21 days on YEN) or the “optimized procedure” (10 days on PDA). This comparison of the infection development was performed for the strains T. rubrum IHEM 13894 and T. benhamiae IHEM 20163. The size of inoculum was determined to induce a fungal invasion restricted to the cornified layer, as can be observed during natural in vivo infection, and appeared to be 1000 CFU for T. rubrum and 30 CFU for T. benhamiae [28].

3.4.1. Adherence to RHE Is Improved for Spores Recovered on PDA

As assessed by morphological analysis, invasion was restricted to the cornified layer, whatever the procedure used for inoculum production (Figure 3A and Figure 4A). Monitoring the fungal load of inoculum by seeding on SAB and subsequently performing CFU counting revealed a number of CFU close to the expected value (i.e., 30 CFU for T. benhamiae and 1000 CFU T. rubrum) (Figure 3B,C and Figure 4B,C). In contrast, the percentage of adherent spores on the tissue surface after four hours of contact appeared significantly higher when the spores were produced on PDA in comparison with spores produced on YEN (Figure 3D and Figure 4D). The more efficient adherence of spores produced on PDA resulted in a tendency towards a greater infection level quantified in the RHE three days or even more four days after their infection (Figure 3E and Figure 4E), as well as for a major impact on the functional integrity of the epidermal barrier (Figure 3F and Figure 4F).

3.4.2. Responses of Keratinocytes to Infection Are More Consistent When Spores Are Produced on PDA

Keratinocyte responses to the infection of RHE by dermatophytes were assessed through measurements of mRNA expression and release in the culture medium of several pro-inflammatory cytokines (IL-1α, IL-1β, IL-8 and TNFα) and antimicrobial peptides (β-defensin-2 (BD2) and -3 (BD3) and cathelicidin LL-37) (Figure 5, Figure 6 and Figure S11). Since a previous report from our team has shown that keratinocyte responses mainly appear near the end of the infection period [29], the expression and release of these factors were monitored on the third and fourth days following infection of the RHE. In accordance with previously obtained results, keratinocytes expressed and released proinflammatory cytokines and antimicrobial peptides mainly on the fourth day following infection, and at similar level whatever the procedure used for spore production, either on YEN or on PDA. However, the variability of keratinocyte responses using the inoculum produced on YEN was very high between replicate assays. This factual observation that has already been reported [29] remains difficult to explain and monitor. In contrast, the reproducibility of the observed keratinocyte responses was improved and quite satisfactory with the inoculum produced on PDA.

4. Discussion

Faced with a still increasing incidence of dermatophytosis [2], together with the emergence of antifungal resistance [10,11,12,13,14], a better understanding of fungal mechanisms involved in the pathogenesis of dermatophytosis, as well as of cellular responses developed by the host, has become crucially awaited in order to rationally define new therapeutic strategies. For this purpose, several in vitro and in vivo infection models have been developed, allowing actual advances in this field [49]. However, unwanted heterogeneity in the production and composition of inocula renders difficult the overall interpretation of observations made on these various models. With the aim to develop some standardized and reproducible procedures for the production of infective spores suitable as inoculum in models, this study characterized several dermatophyte species frequently isolated from human lesions for their growth rate, sporulation, and arthroconidial production in different culture conditions.
Among the five tested media, i.e., SAB, PDA, YPD, MALT, and YEN depicted as classical media for fungal growth, PDA appeared to improve the growth and sporulation of most dermatophyte strains (e.g., T. benhamiae strains and T. mentagrophytes TIMM 2789). For other strains, there was no or little differences between media, especially between PDA and SAB, which also efficiently allowed dermatophyte growth and sporulation (e.g., T. rubrum IHEM 13894 and T. interdigitale IHEM 00584). Furthermore, the growth of Microsporum species, and particularly M. canis IHEM 21239, was slightly increased on YEN, in favour of the previous use of this medium to produce fungal suspensions of M. canis for infection in in vitro [25] and in vivo [26,27] models. However, in order to standardize the medium used for all species and strains, the PDA appears more appropriate.
In accordance with the better fungal growth on PDA, spore suspensions produced from this medium showed a high viable fungal concentration (>106 CFU/mL), sufficient for further use in in vitro and in vivo infection models, as based on the most important published models [15,16] and personal observations. Addition of the stirring step before the filtration during the procedure of recovery increased the viable fungal concentration by allowing a better separation of unicellular spores from hyphae. This stirring step can be performed through vortexing the suspension for one minute (“fast procedure” used in this paper), or by a four-hours shaking at 4 °C (“long procedure”) for an even more efficient separation of spores, and thereby a higher viable fungal concentration. Furthermore, a shorter incubation time on PDA, 10 days instead of 21, did not have a negative impact on the viable fungal concentration for Trichophyton species, which is an advantage in routine laboratory production.
M. audouinii IHEM 10316 and T. tonsurans IHEM 25841 are exceptions, as since very low viable fungal concentrations, of less than 104 and 105 CFU/mL respectively, were obtained for both strains, irrespective of the medium and conditions used, and even after a prolonged incubation of 31 days. Interestingly, the total spore concentration for both these strains appeared to be higher under atmospheric tension compared to incubation under 10% CO2 or 12% CO2, suggesting that incubation of these strains under lower CO2 tension should be an alternative to recover spores to a concentration compatible with their use in infectious models.
Dermatophytes are able to produce two types of spores: micro- and macroconidia resulting from hyphal budding, or arthroconidia derived from hyphal fragmentation. Although arthroconidia are described as natural vectors of dermatophytes [36], they have been less frequently used in experimental models because they remain difficult to produce in culture. Indeed, irregular successes have been described for an efficient in vitro production of arthroconidia [39,40,50,51,52]. Based on previous studies reporting the production of arthroconidia after 10- or 14-day incubation on SAB at 37 °C under 10% CO2 [43,44,52], or after 14–21-day incubation on YEN at 30 °C under 12% CO2 [25], and on our observation that PDA enhances sporulation, we compared the production of arthroconidia by dermatophytes after 10 or 21 days of incubation on SAB, YEN, or PDA, at 37 °C under 10% CO2 or at 30 °C under 12% CO2. Testing these conditions is in agreement with previous reports showing that PDA medium and high CO2 tension are factors that improve dermatophyte sporulation and arthroconidial production [50,53].
In the literature, arthroconidia are described as short-chained or spherical or oval unicellular spores [37,54] and are characterized by the presence of a thicker cell wall when compared to microconidia [55]. In our experience, the morphology of arthroconidia appears highly variable and their identification requires an expert observer, which reinforces the need for molecular tools able to facilitate standardized routine identification of arthroconidia. The proportion of arthroconidia numbered in fungal suspensions recovered after incubation on SAB, PDA and YEN was also highly variable between dermatophytes strains, as well as between the culture medium and condition used, and between replicate assays. In addition, the conditions that enhanced arthroconidial production were not the same as those that allowed a high viable concentration required for subsequent infection in experimental models. Nevertheless, after incubation on PDA at 30 °C under 12% CO2, identified as the optimal culture condition for viable fungal concentration, dermatophytes produce arthroconidia with percentages ranging from 1% to 68% for T. rubrum IHEM 13894 or 82% for M. canis IHEM 21239. The spore suspensions produced in these conditions are therefore “enriched in arthroconidia” compared to suspensions exclusively composed of microconidia and previously used as inoculum in many models [17,18,19,20,21,22,23].
Finally, to ensure that spores produced using PDA at 30 °C under 12% CO2 are able to adhere to and invade host tissue, and thus constitute an adequate inoculum, we evaluated the development of infection by the anthropophilic T. rubrum IHEM 13894 and the zoophilic T. benhamiae IHEM 20163 strains using the pre-established model of dermatophytosis on RHE [28]. Spores produced on PDA were able to invade the tissue, leading to tissue damages through impairment of the epidermal barrier, and inducing responses by keratinocytes, as measured by the expression and release of cytokines and antimicrobial peptides. Strangely, the adherence of spores to the RHE surface after four hours of contact appeared to be increased when the inoculum was produced on PDA compared to the inoculum produced by the conventional method used for the design of the model (i.e., 21 days of incubation on YEN [28]). In addition, the measured responses of keratinocytes, which were pretty variable when spores were produced on YEN, were more reproducible with spores produced on PDA.
In conclusion, this study proposes a standardized procedure for the production of infective spores for use as routine inoculum in experimental models of dermatophytosis. This procedure, summarized in Table 5, allows the recovery of fungal suspensions made of unicellular spores, microconidia but also arthroconidia, at a viable concentration sufficient for infection in in vitro and in vivo models. Standardization of the inocula used in the different experimental models developed by research teams worldwide will facilitate reproducibility and the comparison of observations, leading to more uniform results, which will ultimately improve knowledge of the pathogenesis of dermatophytosis.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/jof7121029/s1, Figure S1: Impact of the culture medium on fungal growth, Figure S2: Impact of the culture medium on the radial growth of dermatophytes, Figure S3: Macroscopic aspect of T. rubrum IHEM 13894 and of T. benhamiae IHEM 20163 colonies, Figure S4: Impact of medium on sporulation of dermatophytes, Figure S5: Viable fungal concentration in infective spore suspensions of Trichophyton species, Figure S6: Viable fungal concentration in infective spore suspensions of Trichophyton mentagrophytes strains, Figure S7: Viable fungal concentration in infective spore suspensions of Microsporum species, Figure S8: Morphology of dermatophyte arthroconidia, Figure S9: Correlation between viable fungal concentration and percentage of arthroconidia in spore suspensions recovered under several culture conditions, Figure S10: Microscopic aspect of spore suspensions of T. rubrum IHEM 13894 and of T. benhamiae IHEM 20163, Figure S11: Keratinocyte responses during (A) T. rubrum IHEM 13894 or (B) T. benhamiae IHEM 20163 infection on reconstructed human epidermis (RHE).

Author Contributions

Conceptualization, E.F., C.S., B.M., and Y.P.; methodology, E.F., C.S., B.M., and Y.P.; validation, E.F., C.S., B.M., and Y.P.; formal analysis, E.F. and C.S.; investigation, E.F., C.S., S.V., C.D., and C.C.; data curation, E.F. and C.S.; writing—original draft preparation, E.F., C.S., B.M., and Y.P.; writing—review and editing, E.F., C.S., B.M., and Y.P.; visualization, E.F. and C.S.; supervision, E.F., C.S., B.M., and Y.P.; project administration, E.F. and C.S.; funding acquisition, E.F., B.M., and Y.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Région Wallonne, MYCEPI grant number 1910074.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Acknowledgments

The authors gratefully acknowledge the technical help provided by V. Bielarz, V. De Glas and F. Marechal. Special thanks to B. Bienfait and JS. Blairvacq for providing human skin samples, and to T. Yamada, from the Institute of Medical Mycology, Teikyo University, for providing the strain T. mentagrophytes TIMM 2789. Special thanks are addressed to M. Salmon and C. Lancelot from the StratiCELL company, Les Isnes, Belgium, for their valuable advice and financial support through the MYCEPI grant.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Weitzman, I.; Summerbell, R.C. The dermatophytes. Clin. Microbiol. Rev. 1995, 8, 240–259. [Google Scholar] [CrossRef]
  2. Havlickova, B.; Czaika, V.A.; Friedrich, M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008, 51, 2–15. [Google Scholar] [CrossRef] [PubMed]
  3. Saunte, D.M.; Holgersen, J.B.; Haedersdal, M.; Strauss, G.; Bitsch, M.; Svendsen, O.L.; Arendrup, M.C.; Svejgaard, E.L. Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm. Venereol. 2006, 86, 425–428. [Google Scholar] [CrossRef] [Green Version]
  4. Gupta, A.K.; Daigle, D.; Foley, K.A. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. J. Eur. Acad. Dermatol. Venereol. 2015, 29, 1039–1044. [Google Scholar] [CrossRef] [PubMed]
  5. Eckhard, M.; Lengler, A.; Liersch, J.; Bretzel, R.G.; Mayser, P. Fungal foot infections in patients with diabetes mellitus—Results of two independent investigations. Mycoses 2007, 50, 14–19. [Google Scholar] [CrossRef] [PubMed]
  6. Sacheli, R.; Cuypers, L.; Seidel, L.; Darfouf, R.; Adjetey, C.; Lagrou, K.; Hayette, M.P. Epidemiology of dermatophytes in Belgium: A 5 years’ survey. Mycopathologia 2021, 186, 399–409. [Google Scholar] [CrossRef] [PubMed]
  7. Gnat, S.; Lagowski, D.; Nowakiewicz, A. Genetic predisposition and its heredity in the context of increased prevalence of dermatophytoses. Mycopathologia 2021, 186, 163–176. [Google Scholar] [CrossRef]
  8. Gupta, A.K.; Foley, K.A.; Versteeg, S.G. New antifungal agents and new formulations against dermatophytes. Mycopathologia 2016, 182, 127–141. [Google Scholar] [CrossRef]
  9. Raschi, E.; Poluzzi, E.; Koci, A.; Caraceni, P.; Ponti, F.D. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database. World J. Hepatol. 2014, 6, 601–612. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Monod, M.; Feuermann, M.; Salamin, K.; Fratti, M.; Makino, M.; Alshahni, M.M.; Makimura, K.; Yamada, T. Trichophyton rubrum azole resistance mediated by a new ABC transporter, TruMDR3. Antimicrob. Agents Chemother. 2019, 63, e00863-19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Lagowski, D.; Gnat, S.; Nowakiewicz, A.; Osinska, M.; Dylag, M. Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase. Infection 2020, 48, 889–897. [Google Scholar] [CrossRef]
  12. Kakurai, M.; Harada, K.; Maeda, T.; Hiruma, J.; Kano, R.; Demitsu, T. Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale. J. Dermatol. 2020, 47, e104–e105. [Google Scholar] [CrossRef]
  13. Gu, D.; Hatch, M.; Ghannoum, M.; Elewski, B.E. Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat. JAAD Case Rep. 2020, 6, 1153–1155. [Google Scholar] [CrossRef] [PubMed]
  14. Gaurav, V.; Bhattacharya, S.N.; Sharma, N.; Datt, S.; Kumar, P.; Rai, G.; Singh, P.K.; Taneja, B.; Das, S. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy. J. Mycol. Med. 2021, 31, 101087. [Google Scholar] [CrossRef]
  15. Faway, E.; Lambert de Rouvroit, C.; Poumay, Y. In vitro models of dermatophyte infection to investigate epidermal barrier alterations. Exp. Dermatol. 2018, 27, 915–922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Cambier, L.; Heinen, M.P.; Mignon, B. Relevant animal models in dermatophyte research. Mycopathologia 2017, 182, 229–240. [Google Scholar] [CrossRef]
  17. Achterman, R.R.; Moyes, D.L.; Thavaraj, S.; Smith, A.R.; Blair, K.M.; White, T.C.; Naglik, J.R. Dermatophytes activate skin keratinocytes via mitogen-activated protein kinase signaling and induce immune responses. Infect. Immun. 2015, 83, 1705–1714. [Google Scholar] [CrossRef] [Green Version]
  18. Liang, P.; Huang, X.; Yi, J.; Chen, Z.; Ma, H.; Ye, C.; Chen, X.; Lai, W.; Chen, J. Trichophyton rubrum infection model based on the reconstructed human epidermis—Episkin. Chin. Med. J. 2016, 129, 54–58. [Google Scholar] [CrossRef] [PubMed]
  19. Shi, Y.; Niu, Q.; Yu, X.; Jia, X.; Wang, J.; Lin, D.; Jin, Y. Assessment of the function of SUB6 in the pathogenic dermatophyte Trichophyton mentagrophytes. Med. Mycol. 2016, 54, 59–71. [Google Scholar]
  20. Burstein, V.L.; Guasconi, L.; Beccacece, I.; Theumer, M.G.; Mena, C.; Prinz, I.; Cervi, L.; Herrero, M.; Masih, D.T.; Chiapello, L.S. IL-17-mediated immunity controls skin infection and T Helper 1 response during experimental Microsporum canis dermatophytosis. J. Investig. Dermatol. 2018, 138, 1744–1753. [Google Scholar] [CrossRef] [Green Version]
  21. Heinen, M.P.; Cambier, L.; Antoine, N.; Gabriel, A.; Gillet, L.; Bureau, F.; Mignon, B. Th1 and Th17 immune responses act complementarily to optimally control superficial dermatophytosis. J. Investig. Dermatol. 2019, 139, 626–637. [Google Scholar] [CrossRef] [Green Version]
  22. Baumbach, C.M.; Michler, J.K.; Nenoff, P.; Uhrlass, S.; Schrodl, W. Visualising virulence factors: Trichophyton benhamiae subtilisins demonstrated in a guinea pig skin ex vivo model. Mycoses 2020, 63, 970–978. [Google Scholar] [CrossRef]
  23. Baumbach, C.M.; Schrodl, W.; Nenoff, P.; Uhrlass, S.; Mulling, C.K.W.; Michler, J.K. Modeling dermatophytosis: Guinea pig skin explants represent a highly suitable model to study Trichophyton benhamiae infections. J. Dermatol. 2020, 47, 8–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Fujita, S.; Matsuyama, T. Experimental tinea pedis induced by non-abrasive inoculation of Trichophyton mentagrophytes arthrospores on the plantar part of a guinea pig foot. J. Med. Vet. Mycol. 1987, 25, 203–213. [Google Scholar] [CrossRef]
  25. Tabart, J.; Baldo, A.; Vermout, S.; Nusgens, B.; Lapiere, C.; Losson, B.; Mignon, B. Reconstructed interfollicular feline epidermis as a model for Microsporum canis dermatophytosis. J. Med. Microbiol. 2007, 56, 971–975. [Google Scholar] [CrossRef] [Green Version]
  26. Baldo, A.; Mathy, A.; Tabart, J.; Camponova, P.; Vermout, S.; Massart, L.; Marechal, F.; Galleni, M.; Mignon, B. Secreted subtilisin Sub3 from Microsporum canis is required for adherence to but not for invasion of the epidermis. Br. J. Dermatol. 2010, 162, 990–997. [Google Scholar] [CrossRef]
  27. Cambier, L.; Bagut, E.T.; Heinen, M.P.; Tabart, J.; Antoine, N.; Mignon, B. Assessment of immunogenicity and protective efficacy of Microsporum canis secreted components coupled to monophosphoryl lipid-A adjuvant in a vaccine study using guinea pigs. Vet. Microbiol. 2015, 175, 304–311. [Google Scholar] [CrossRef]
  28. Faway, E.; Cambier, L.; Mignon, B.; Poumay, Y.; Lambert de Rouvroit, C. Modeling dermatophytosis in reconstructed human epidermis: A new tool to study infection mechanisms and to test antifungal agents. Med. Mycol. 2017, 55, 485–494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Faway, E.; Cambier, L.; De Vuyst, E.; Evrard, C.; Thiry, M.; Lambert de Rouvroit, C.; Mignon, B.; Poumay, Y. Responses of reconstructed human epidermis to Trichophyton rubrum infection and impairment of infection by the inhibitor PD169316. J. Investig. Dermatol. 2019, 139, 2080–2089. [Google Scholar] [CrossRef]
  30. Odds, F.; Ausma, J.; Van Gerven, F.; Woestenborghs, F.; Meerpoel, L.; Heeres, J.; Vanden Bossche, H.; Borgers, M. In vitro and in vivo activities of the novel antifungal agent r126638. Antimicrob. Agents Chemother. 2004, 48, 388–391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Staib, P.; Zaugg, C.; Mignon, B.; Weber, J.; Grumbt, M.; Pradervand, S.; Harshman, K.; Monod, M. Differential gene expression in the pathogenic dermatophyte Arthroderma benhamiae in vitro versus during infection. Microbiology 2010, 156, 884–895. [Google Scholar] [CrossRef] [Green Version]
  32. Grumbt, M.; Defaweux, V.; Mignon, B.; Monod, M.; Burmester, A.; Wostemeyer, J.; Staib, P. Targeted gene deletion and in vivo analysis of putative virulence gene function in the pathogenic dermatophyte Arthroderma benhamiae. Eukaryot. Cell 2011, 10, 842–853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Cambier, L.; Weatherspoon, A.; Defaweux, V.; Bagut, E.T.; Heinen, M.P.; Antoine, N.; Mignon, B. Assessment of the cutaneous immune response during Arthroderma benhamiae and A. vanbreuseghemii infection using an experimental mouse model. Br. J. Dermatol. 2014, 170, 625–633. [Google Scholar] [CrossRef]
  34. Singh, G.; Kumar, P.; Joshi, S.C. Treatment of dermatophytosis by a new antifungal agent ‘apigenin’. Mycoses 2014, 57, 497–506. [Google Scholar] [CrossRef]
  35. Tran, V.D.; De Coi, N.; Feuermann, M.; Schmid-Siegert, E.; Bagut, E.T.; Mignon, B.; Waridel, P.; Peter, C.; Pradervand, S.; Pagni, M.; et al. RNA sequencing-based genome reannotation of the dermatophyte Arthroderma benhamiae and characterization of its secretome and whole gene expression profile during infection. mSystems 2016, 1, 00036-16. [Google Scholar] [CrossRef] [Green Version]
  36. Rashid, A. Arthroconidia as vectors of dermatophytosis. Cutis 2001, 67, 23. [Google Scholar] [PubMed]
  37. Hashimoto, T.; Blumenthal, H.J. Factors affecting germination of Trichophyton mentagrophytes arthrospores. Infect. Immun. 1977, 18, 479–486. [Google Scholar] [CrossRef] [Green Version]
  38. Hoff, B.; Schmitt, E.K.; Kuck, U. CPCR1, but not its interacting transcription factor AcFKH1, controls fungal arthrospore formation in Acremonium chrysogenum. Mol. Microbiol. 2005, 56, 1220–1233. [Google Scholar] [CrossRef]
  39. Bibel, D.J.; Crumrine, D.A.; Yee, K.; King, R.D. Development of arthrospores of Trichophyton mentagrophytes. Infect. Immun. 1977, 15, 958–971. [Google Scholar] [CrossRef] [Green Version]
  40. Hashimoto, T.; Blumenthal, H.J. Survival and resistance of Trichophyton mentagrophytes arthrospores. Appl. Environ. Microbiol. 1978, 35, 274–277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Weigl, E.; Hejtmanek, M. Differentiation of Trichophyton mentagrophytes arthrospores controlled by physical factors. Mycoses 1979, 22, 167–172. [Google Scholar] [CrossRef] [PubMed]
  42. Wright, L.R.; Scott, E.M.; Gorman, S.P. Spore differentiation in a clinical strain of Trichophyton mentagrophytes. Microbios 1984, 39, 87–93. [Google Scholar]
  43. Yazdanparast, S.A.; Barton, R.C. Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis. J. Med. Microbiol. 2006, 55, 1577–1581. [Google Scholar] [CrossRef] [Green Version]
  44. Farnoodian, M.; Yazdanparast, S.A.; Sadri, M.F. Effects of environmental factors and selected antifungal agents on arthroconidia production in common species of Trichophyton genus and Epidermophyton floccosum. J. Biol. Sci. 2009, 9, 561–566. [Google Scholar] [CrossRef] [Green Version]
  45. Alshahni, M.M.; Yamada, T.; Yo, A.; Murayama, S.Y.; Kuroda, M.; Hoshino, Y.; Ishikawa, J.; Watanabe, S.; Makimura, K. Insight into the draft whole-genome sequence of the dermatophyte Arthroderma vanbreuseghemii. Sci. Rep. 2018, 8, 15127. [Google Scholar] [CrossRef]
  46. De Vuyst, E.; Charlier, C.; Giltaire, S.; De Glas, V.; Lambert de Rouvroit, C.; Poumay, Y. Reconstruction of normal and pathological human epidermis on polycarbonate filter. Methods Mol. Biol. 2014, 1195, 191–201. [Google Scholar] [PubMed]
  47. Paugam, A.; L’Ollivier, C.; Viguie, C.; Anaya, L.; Mary, C.; de Ponfilly, G.; Ranque, S. Comparison of real-time PCR with conventional methods to detect dermatophytes in samples from patients with suspected dermatophytosis. J. Microbiol. Methods 2013, 95, 218–222. [Google Scholar] [CrossRef] [PubMed]
  48. Minner, F.; Poumay, Y. Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J. Investig. Dermatol. 2009, 129, 770–773. [Google Scholar] [CrossRef] [Green Version]
  49. Faway, E.; Thiry, M.; Mignon, B.; Poumay, Y. Experimental models of dermatophytosis. In Dermatophytes and Dermatophytosis; Bouchara, J., Nenoff, P., Gupta, A.K., Chaturvedi, V., Eds.; Springer: Cham, Switzerland, 2021; pp. 135–160. [Google Scholar]
  50. Chin, B.; Knight, S.G. Growth of Trichophyton mentagrophytes and Trichophyton rubrum in increased carbon dioxide tensions. J. Gen. Microbiol. 1957, 16, 642–646. [Google Scholar] [CrossRef] [Green Version]
  51. Emyanitoff, R.G.; Hashimoto, T. The effects of temperature, incubation atmosphere, and medium composition on arthrospore formation in the fungus Trichophyton mentagrophytes. Can. J. Microbiol. 1979, 25, 362–366. [Google Scholar] [CrossRef]
  52. Gupta, A.K.; Ahmad, I.; Porretta, M.; Summerbell, R.C. Arthroconidial formation in Trichophyton raubitschekii. Mycoses 2003, 46, 322–328. [Google Scholar] [CrossRef]
  53. Laurent, A.; Monod, M. Production of Trichophyton rubrum microspores in large quantities and its application to evaluate amorolfine/azole compound interactions in vitro. Mycoses 2017, 60, 581–586. [Google Scholar] [CrossRef] [PubMed]
  54. Rippon, J.W.; Scherr, G.H. Induced dimorphism in dermatophytes. Mycologia 1959, 51, 902–914. [Google Scholar] [CrossRef]
  55. Zurita, J.; Hay, R.J. Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J. Investig. Dermatol. 1987, 89, 529–534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Jof 07 01029 g001 550
Figure 1. Growth and sporulation of T. rubrum IHEM 13894. T. rubrum IHEM 13894 were seeded over five agar media, Sabouraud (SAB), Potato Dextrose Agar (PDA), Yeast Peptone Dextrose (YPD), Malt medium (MALT) or Yeast Extract Nitrogen (YEN), and grown at 30 °C for 31 days. Fungal material was then scrapped, suspended in PBS and filtered to obtain fungal suspensions. (A) Diameter of fungal colonies was measured daily, (B) radial growth was determined during the exponential phase of growth, and (C) the total spore concentration recovered in fungal suspension was determined by counting using a Thoma chamber under light microscopy. To promote sporulation and arthroconidial production by T. rubrum IHEM 13894, fungi were seeded on SAB, PDA or YEN media, and incubated at 30 °C under 12% CO2 or at 37 °C under 10% CO2, for 10 or 21 days. Fungal material was then scrapped, suspended in PBS, stirred and filtered to obtain spore suspensions. (D) Viable fungal concentration was determined by counting colony-forming units (CFU). (E) Morphology of arthroconidia (white arrow) was observed using differential interference contrast (DIC) microscopy. Scale bar = 10 µm. (F) Viable fungal concentration was correlated with the proportion of arthroconidia relative to the total number of fungal elements, determined by counting using a Thoma chamber under light microscopy. Dotted lines indicate the minimal viable fungal concentration required for further use on experimental models, based on the most important published models [15,16] and personal observations, as well as the proportion of 20% arthroconidia, arbitrarily chosen as a minimal value for suspensions enriched in arthroconidia. Data analysis: n ≥ 3; means ± SD for (A), means and individual values for (B–D), and single plots for (F); ANOVA2 for (B–D) compared to PDA; **** p < 0.0001.
Figure 1. Growth and sporulation of T. rubrum IHEM 13894. T. rubrum IHEM 13894 were seeded over five agar media, Sabouraud (SAB), Potato Dextrose Agar (PDA), Yeast Peptone Dextrose (YPD), Malt medium (MALT) or Yeast Extract Nitrogen (YEN), and grown at 30 °C for 31 days. Fungal material was then scrapped, suspended in PBS and filtered to obtain fungal suspensions. (A) Diameter of fungal colonies was measured daily, (B) radial growth was determined during the exponential phase of growth, and (C) the total spore concentration recovered in fungal suspension was determined by counting using a Thoma chamber under light microscopy. To promote sporulation and arthroconidial production by T. rubrum IHEM 13894, fungi were seeded on SAB, PDA or YEN media, and incubated at 30 °C under 12% CO2 or at 37 °C under 10% CO2, for 10 or 21 days. Fungal material was then scrapped, suspended in PBS, stirred and filtered to obtain spore suspensions. (D) Viable fungal concentration was determined by counting colony-forming units (CFU). (E) Morphology of arthroconidia (white arrow) was observed using differential interference contrast (DIC) microscopy. Scale bar = 10 µm. (F) Viable fungal concentration was correlated with the proportion of arthroconidia relative to the total number of fungal elements, determined by counting using a Thoma chamber under light microscopy. Dotted lines indicate the minimal viable fungal concentration required for further use on experimental models, based on the most important published models [15,16] and personal observations, as well as the proportion of 20% arthroconidia, arbitrarily chosen as a minimal value for suspensions enriched in arthroconidia. Data analysis: n ≥ 3; means ± SD for (A), means and individual values for (B–D), and single plots for (F); ANOVA2 for (B–D) compared to PDA; **** p < 0.0001.
Jof 07 01029 g001
Jof 07 01029 g002 550
Figure 2. Growth and sporulation of T. benhamiae IHEM 20163. T. benhamiae IHEM 20163 were seeded over five agar media, Sabouraud (SAB), Potato Dextrose Agar (PDA), Yeast Peptone Dextrose (YPD), Malt medium (MALT) or Yeast Extract Nitrogen (YEN), and grown at 30 °C for 31 days. Fungal material was then scrapped, suspended in PBS and filtered to obtain fungal suspensions. (A) Diameter of fungal colonies was measured daily, (B) radial growth was determined during the exponential phase of growth, and (C) the total spore concentration recovered in fungal suspension was determined by counting using a Thoma chamber under light microscopy. To promote sporulation and arthroconidial production by T. benhamiae IHEM 20163, fungi were seeded on SAB, PDA or YEN media, and incubated at 30 °C under 12% CO2 or at 37 °C under 10% CO2, for 10 or 21 days. Fungal material was then scrapped, suspended in PBS, stirred and filtered to obtain spore suspensions. (D) Viable fungal concentration was determined by counting colony-forming units (CFU). (E) Morphology of arthroconidia (white arrow) was observed using differential interference contrast (DIC) microscopy. Scale bar = 10 µm. (F) Viable fungal concentration was correlated with the proportion of arthroconidia relative to the total number of fungal elements, determined by counting using a Thoma chamber under light microscopy. Dotted lines indicate the minimal viable fungal concentration required for further use on experimental models, based on the most important published models [15,16] and personal observations, as well as the proportion of 20% arthroconidia, arbitrarily chosen as a minimal value for suspensions enriched in arthroconidia. Data analysis: n ≥ 3; means ± SD for (A), means and individual values for (B–D), and single plots for (F); ANOVA2 for (B–D) compared to PDA; ** p < 0.01 *** p < 0.001 **** p < 0.0001.
Figure 2. Growth and sporulation of T. benhamiae IHEM 20163. T. benhamiae IHEM 20163 were seeded over five agar media, Sabouraud (SAB), Potato Dextrose Agar (PDA), Yeast Peptone Dextrose (YPD), Malt medium (MALT) or Yeast Extract Nitrogen (YEN), and grown at 30 °C for 31 days. Fungal material was then scrapped, suspended in PBS and filtered to obtain fungal suspensions. (A) Diameter of fungal colonies was measured daily, (B) radial growth was determined during the exponential phase of growth, and (C) the total spore concentration recovered in fungal suspension was determined by counting using a Thoma chamber under light microscopy. To promote sporulation and arthroconidial production by T. benhamiae IHEM 20163, fungi were seeded on SAB, PDA or YEN media, and incubated at 30 °C under 12% CO2 or at 37 °C under 10% CO2, for 10 or 21 days. Fungal material was then scrapped, suspended in PBS, stirred and filtered to obtain spore suspensions. (D) Viable fungal concentration was determined by counting colony-forming units (CFU). (E) Morphology of arthroconidia (white arrow) was observed using differential interference contrast (DIC) microscopy. Scale bar = 10 µm. (F) Viable fungal concentration was correlated with the proportion of arthroconidia relative to the total number of fungal elements, determined by counting using a Thoma chamber under light microscopy. Dotted lines indicate the minimal viable fungal concentration required for further use on experimental models, based on the most important published models [15,16] and personal observations, as well as the proportion of 20% arthroconidia, arbitrarily chosen as a minimal value for suspensions enriched in arthroconidia. Data analysis: n ≥ 3; means ± SD for (A), means and individual values for (B–D), and single plots for (F); ANOVA2 for (B–D) compared to PDA; ** p < 0.01 *** p < 0.001 **** p < 0.0001.
Jof 07 01029 g002
Jof 07 01029 g003 550
Figure 3. T. rubrum IHEM 13894 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. rubrum IHEM 13894 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum was adjusted to a density of 1000 colony-forming units (CFU) per RHE. (A) Histological sections were prepared from infected RHE analysed one (D0+1d), two (D0+2d), three (D0+3d) or four (D0+4d) days after infection and then stained using the Periodic-acid Schiff (PAS) procedure with α-amylase pre-treatment and hemalun counterstaining. Scale bar = 50 µm. (B) Fungal load of inoculum was monitored by counting CFU, the dotted line indicates the expected size of inoculum, and (C) the macroscopic aspect of CFU was observed. Scale bars = 1 mm. (D) Percentage of spores adhering to the epidermis was determined four hours after infection. (E) Infection levels were assessed three (D0+3d) and four (D0+4d) days after infection of RHE using qPCR analysis of the rDNA 18S gene copy numbers of T. rubrum in total DNA extracts prepared from infected RHE (YEN and PDA) or non-infected RHE (CTL). (F) Epidermal barrier integrity of RHE during infection was determined by measurements of trans-epithelial electrical resistance (TEER). TEER values are expressed as percentage of values measured before RHE infection (D0). Data analysis: n = 3; means ± SD; ANOVA1 for (B,D), ANOVA2 for (E,F); * p < 0.05 ** p < 0.01 *** p < 0.001.
Figure 3. T. rubrum IHEM 13894 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. rubrum IHEM 13894 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum was adjusted to a density of 1000 colony-forming units (CFU) per RHE. (A) Histological sections were prepared from infected RHE analysed one (D0+1d), two (D0+2d), three (D0+3d) or four (D0+4d) days after infection and then stained using the Periodic-acid Schiff (PAS) procedure with α-amylase pre-treatment and hemalun counterstaining. Scale bar = 50 µm. (B) Fungal load of inoculum was monitored by counting CFU, the dotted line indicates the expected size of inoculum, and (C) the macroscopic aspect of CFU was observed. Scale bars = 1 mm. (D) Percentage of spores adhering to the epidermis was determined four hours after infection. (E) Infection levels were assessed three (D0+3d) and four (D0+4d) days after infection of RHE using qPCR analysis of the rDNA 18S gene copy numbers of T. rubrum in total DNA extracts prepared from infected RHE (YEN and PDA) or non-infected RHE (CTL). (F) Epidermal barrier integrity of RHE during infection was determined by measurements of trans-epithelial electrical resistance (TEER). TEER values are expressed as percentage of values measured before RHE infection (D0). Data analysis: n = 3; means ± SD; ANOVA1 for (B,D), ANOVA2 for (E,F); * p < 0.05 ** p < 0.01 *** p < 0.001.
Jof 07 01029 g003
Jof 07 01029 g004 550
Figure 4. T. benhamiae IHEM 20163 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. benhamiae IHEM 20163 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum was adjusted to a density of 30 colony-forming units (CFU) per RHE. (A) Histological sections were prepared from infected RHE analysed one (D0+1d), two (D0+2d), three (D0+3d) or four (D0+4d) days after infection and then stained using the Periodic-acid Schiff (PAS) procedure with α-amylase pre-treatment and hemalun counterstaining. Scale bar = 50 µm. (B) Fungal load of inoculum was monitored by counting CFU, the dotted line indicates the expected size of inoculum, and (C) the macroscopic aspect of CFU was observed. Scale bars = 1 mm. (D) Percentage of spores adhering to the epidermis was determined four hours after infection. (E) Infection levels were assessed three (D0+3d) and four (D0+4d) days after infection of RHE using qPCR analysis of the rDNA 18S gene copy numbers of T. benhamiae in total DNA extracts prepared from infected RHE (YEN and PDA) or non-infected RHE (CTL). (F) Epidermal barrier integrity of RHE during infection was determined by measurements of trans-epithelial electrical resistance (TEER). TEER values are expressed as percentage of values measured before RHE infection (D0). Data analysis: n = 3; means ± SD; ANOVA1 for (B,D), ANOVA2 for (E,F); * p < 0.05 ** p < 0.01 *** p < 0.001.
Figure 4. T. benhamiae IHEM 20163 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. benhamiae IHEM 20163 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum was adjusted to a density of 30 colony-forming units (CFU) per RHE. (A) Histological sections were prepared from infected RHE analysed one (D0+1d), two (D0+2d), three (D0+3d) or four (D0+4d) days after infection and then stained using the Periodic-acid Schiff (PAS) procedure with α-amylase pre-treatment and hemalun counterstaining. Scale bar = 50 µm. (B) Fungal load of inoculum was monitored by counting CFU, the dotted line indicates the expected size of inoculum, and (C) the macroscopic aspect of CFU was observed. Scale bars = 1 mm. (D) Percentage of spores adhering to the epidermis was determined four hours after infection. (E) Infection levels were assessed three (D0+3d) and four (D0+4d) days after infection of RHE using qPCR analysis of the rDNA 18S gene copy numbers of T. benhamiae in total DNA extracts prepared from infected RHE (YEN and PDA) or non-infected RHE (CTL). (F) Epidermal barrier integrity of RHE during infection was determined by measurements of trans-epithelial electrical resistance (TEER). TEER values are expressed as percentage of values measured before RHE infection (D0). Data analysis: n = 3; means ± SD; ANOVA1 for (B,D), ANOVA2 for (E,F); * p < 0.05 ** p < 0.01 *** p < 0.001.
Jof 07 01029 g004
Jof 07 01029 g005 550
Figure 5. Keratinocytes responses during T. rubrum IHEM 13894 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. rubrum IHEM 13894 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum has been adjusted in each case to a density of 1000 colony-forming units (CFU) per RHE. (A) mRNA expression of antimicrobial peptides (BD2, BD3) and pro-inflammatory cytokines (IL-1α, IL-8) and (B) release of IL-1α and IL-8 by infected RHE, three (D0+3d) and four (D0+4d) days after infection, or by non-infected RHE (CTL) were assessed respectively by RT-qPCR and ELISA. Data analysis: n = 3; means ± SD; ANOVA2; * p < 0.05 ** p < 0.01.
Figure 5. Keratinocytes responses during T. rubrum IHEM 13894 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. rubrum IHEM 13894 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum has been adjusted in each case to a density of 1000 colony-forming units (CFU) per RHE. (A) mRNA expression of antimicrobial peptides (BD2, BD3) and pro-inflammatory cytokines (IL-1α, IL-8) and (B) release of IL-1α and IL-8 by infected RHE, three (D0+3d) and four (D0+4d) days after infection, or by non-infected RHE (CTL) were assessed respectively by RT-qPCR and ELISA. Data analysis: n = 3; means ± SD; ANOVA2; * p < 0.05 ** p < 0.01.
Jof 07 01029 g005
Jof 07 01029 g006 550
Figure 6. Keratinocytes responses during T. benhamiae IHEM 20163 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. benhamiae IHEM 20163 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum has been adjusted in each case to a density of 30 colony-forming units (CFU) per RHE. (A) mRNA expression of antimicrobial peptides (BD2, BD3) and pro-inflammatory cytokines (IL-1α, IL-8) and (B) release of IL-1α and IL-8 by infected RHE, three (D0+3d) and four (D0+4d) days after infection, or by non-infected RHE (CTL) were assessed respectively by RT-qPCR and ELISA. Data analysis: n = 3; means ± SD; ANOVA2; * p < 0.05 ** p < 0.01 *** p < 0.001.
Figure 6. Keratinocytes responses during T. benhamiae IHEM 20163 infection on reconstructed human epidermis (RHE). RHE were infected on day zero (D0) by topical addition of inoculum consisting in suspensions of T. benhamiae IHEM 20163 spores recovered after 21 days of incubation over Yeast Extract Nitrogen agar (YEN) at 30 °C under 12% CO2, or after 10 days of incubation over Potato Dextrose Agar (PDA) in the same conditions. The inoculum has been adjusted in each case to a density of 30 colony-forming units (CFU) per RHE. (A) mRNA expression of antimicrobial peptides (BD2, BD3) and pro-inflammatory cytokines (IL-1α, IL-8) and (B) release of IL-1α and IL-8 by infected RHE, three (D0+3d) and four (D0+4d) days after infection, or by non-infected RHE (CTL) were assessed respectively by RT-qPCR and ELISA. Data analysis: n = 3; means ± SD; ANOVA2; * p < 0.05 ** p < 0.01 *** p < 0.001.
Jof 07 01029 g006
Table
Table 1. Dermatophyte isolates analysed in this study. Information on each isolate was retrieved from the online catalogue of Belgian Coordinated Collections of Micro-organisms (BCCM)/Institute of Hygiene and Epidemiology-Mycology section (IHEM; https://bccm.belspo.be/catalogues/ihem-catalogue-search; accessed on 1 September 2021).
Table 1. Dermatophyte isolates analysed in this study. Information on each isolate was retrieved from the online catalogue of Belgian Coordinated Collections of Micro-organisms (BCCM)/Institute of Hygiene and Epidemiology-Mycology section (IHEM; https://bccm.belspo.be/catalogues/ihem-catalogue-search; accessed on 1 September 2021).
Genus—Species—
Isolate Number		Isolation
YearLesionHostCountry
Microsporum
M. audouinii IHEM 103161997Tinea capitisHumanBelgium
M. canis IHEM 229572009TineaCatBelgium
M. canis IHEM 229582009TineaCatBelgium
M. canis IHEM 212392005TineaCatBelgium
Trichophyton
T. benhamiae IHEM 201632002Tinea corporisHumanSwitzerland
T. benhamiae IHEM 201612002Tinea facieiHumanSwitzerland
T. interdigitale IHEM 005841981Tinea pedisHumanBelgium
T. mentagrophytes IHEM 227402008SkinHumanSwitzerland
T. mentagrophytes IHEM 227332008TineaCatSwitzerland
T. mentagrophytes IHEM 258412012Skin and hairsDogBelgium
T. mentagrophytes TIMM 2789 1
T. rubrum IHEM 138941985Tinea cruris and onychomycosisHumanDemocratic Republic of the Congo
T. tonsurans IHEM 249582008 HumanBelgium
1 The strain T. mentagrophytes TIMM 2789 was gracefully supplied by T. Yamada from the Institute of Medical Mycology, Teikyo University [45].
Table
Table 2. Composition of agar media used in this study.
Table 2. Composition of agar media used in this study.
Composition in g/LSabouraud
(SAB)		Potato Dextrose
Agar
(PDA)		Yeast Peptone Dextrose (YPD)Malt Medium (MALT)Yeast Extract Nitrogen (YEN)
Tryptone 110 20610
Glucose 220 20
Potato dextrose
agar 3		 39
Malt extract 4 20
Yeastextract 5 10 20
Agar 6205202020
pH7.5 ± 0.35.4 ± 0.57.5 ± 0.16.1 ± 0.27.3 ± 0.2
1 Tryptone (peptone from casein) cat. no. 84610.0500; VWR Chemicals, Radnor, PA, USA; 2 D(+)-Glucose monohydrate, + de 99 %, extra pur cat. no. 450740010; Acros-organics B.V.B.A, Fisher Scientific, Fair Lawn, NJ, USA; 3 Potato dextrose agar cat. no. 110130; Merck KGaA, Darmstadt, Germany; 4 Malt Extract cat. no. 1.05391.0500; Merck KGaA, Darmstadt, Germany; 5 Yeast extract cat. no. 84601.0500; VWR Chemicals, Radnor, PA, USA; 6 Agar cat. no. BP-1423-2; VWR Chemicals, Radnor, PA, USA.
Table
Table 3. Sequences of primer pairs used for RT-qPCR.
Table 3. Sequences of primer pairs used for RT-qPCR.
Gene SymbolForward PrimerReverse Primer
BD25′-ATCAGCCATGAGGGTCTTGT-3′5′-GAGACCACAGGTGCCAATTT-3′
BD35′-TCCAGGTCATGGAGGAATCAT-3′5′-CGAGCACTTGCCGATCTGT-3′
IL-1α5′-AACCAGTGCTGCTGAAGGAGAT-3′5′-TGGTCTCACTACCTGTGATGGTTT-3′
IL-1β5′-TCCCCAGCCCTTTTGTTGA-3′5′-TTAGAACCAAATGTGGCCGTG-3′
IL-85′-GCAGAGGGTTGTGGAGAAGTTT-3′5′-TTGGATACCACAGAGAATGAATTTTT-3′
LL-375′-CCAGGACGACACAGCAGTCA-3′5′-CTTCACCAGCCCGTCCTTC-3′
RPLP05′-ATCAACGGGTACAAACGAGTC-3′5′-CAGATGGATCAGCCAAGAAGG-3′
TNFα5′-GAGGCCAAGCCCTGGTATG-3′5′-CGGGCCGATTGATCTCAGC-3′
Table
Table 4. Minimum and maximum proportions of arthroconidia produced after 10, 21 or 31 days of incubation on PDA at 30 °C under 12% CO2.
Table 4. Minimum and maximum proportions of arthroconidia produced after 10, 21 or 31 days of incubation on PDA at 30 °C under 12% CO2.
Genus—Species—
Isolate Number		Incubation Duration (Days)Proportion of Arthroconidia (%)
MinMax
Microsporum
M. audouinii IHEM 1031610nd 1nd
21ndnd
31nd67
M. canis IHEM 2295721nd17
M. canis IHEM 2295821367
M. canis IHEM 2123921182
Trichophyton
T. benhamiae IHEM 2016110121
T. benhamiae IHEM 201631011
T. interdigitale IHEM 005841019
T. mentagrophytes IHEM 22733101424
T. mentagrophytes IHEM 22740103066
T. mentagrophytes IHEM 2584110115
T. mentagrophytes TIMM 27891039
T. rubrum IHEM 1389410468
T. tonsurans IHEM 249581060 100
2129100
317293
1 A percentage below the limit of detection by Thoma chamber enumeration is indicated as “not determined” (nd).
Table
Table 5. Recommendations for a standardized procedure for the production of infective spores useable as inoculum in in vitro and in vivo experimental models.
Table 5. Recommendations for a standardized procedure for the production of infective spores useable as inoculum in in vitro and in vivo experimental models.
StepProcedure AimComment
PrecultureIncubation for 14 days on SAB at 30 °CGrowth of the starting fungal material
Recovering of fungal material by scraping and suspension in PBS
SporulationSeeding on PDA and incubation for 10 days at 30 °C under 12% CO2Production of unicellular spores, mainly microconidia, and to a lesser extent arthroconidia21 days required for Microsporum spp.
Recovering of fungal material by scraping and suspension in PBS
AgitationFour hours at 4 °C using magnetic stirrerSeparation of unicellular spores from hyphaeOne-minute vortexing for fast procedure (reduced efficiency)
FiltrationThrough three Miracloth layersRecovery of unicellular elements onlyShort hyphae can sometimes pass through the Miracloth filter
WashingCentrifugation of the spore suspension at 3000× g for 5 min, discarding of the supernatant and resuspension of the pellet in PBSElimination of medium residuesRepeat until obtention of a clear supernatant, and at least three times
Final suspensionResuspension of the pellet in an appropriate volume of PBS depending of the size of the pellet and of the final spore concentration wanted Store spore suspensions at 4 °C and use within one month
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Faway, E.; Staerck, C.; Danzelle, C.; Vroomen, S.; Courtain, C.; Mignon, B.; Poumay, Y. Towards a Standardized Procedure for the Production of Infective Spores to Study the Pathogenesis of Dermatophytosis. J. Fungi 2021, 7, 1029. https://doi.org/10.3390/jof7121029

AMA Style

Faway E, Staerck C, Danzelle C, Vroomen S, Courtain C, Mignon B, Poumay Y. Towards a Standardized Procedure for the Production of Infective Spores to Study the Pathogenesis of Dermatophytosis. Journal of Fungi. 2021; 7(12):1029. https://doi.org/10.3390/jof7121029

Chicago/Turabian Style

Faway, Emilie, Cindy Staerck, Célya Danzelle, Sophie Vroomen, Christel Courtain, Bernard Mignon, and Yves Poumay. 2021. "Towards a Standardized Procedure for the Production of Infective Spores to Study the Pathogenesis of Dermatophytosis" Journal of Fungi 7, no. 12: 1029. https://doi.org/10.3390/jof7121029

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop